Frontiers in Medicine,
Journal Year:
2020,
Volume and Issue:
7
Published: Dec. 23, 2020
The
coronavirus
disease
2019
(COVID-19)
pandemic
continues
to
have
a
tremendous
impact
on
patients
and
healthcare
systems
around
the
world.
In
fight
against
this
novel
disease,
there
is
pressing
need
for
rapid
effective
screening
tools
identify
infected
with
COVID-19,
end
CT
imaging
has
been
proposed
as
one
of
key
methods
which
may
be
used
complement
RT-PCR
testing,
particularly
in
situations
where
undergo
routine
scans
non-COVID-19
related
reasons,
worsening
respiratory
status
or
developing
complications
that
require
expedited
care,
are
suspected
COVID-19-positive
but
negative
test
results.
Early
studies
CT-based
reported
abnormalities
chest
images
characteristic
COVID-19
infection,
these
difficult
distinguish
from
caused
by
other
lung
conditions.
Motivated
this,
study
we
introduce
COVIDNet-CT,
deep
convolutional
neural
network
architecture
tailored
detection
cases
via
machine-driven
design
exploration
approach.
Additionally,
COVIDx-CT,
benchmark
image
dataset
derived
data
collected
China
National
Center
Bioinformation
comprising
104,009
across
1,489
patient
cases.
Furthermore,
interest
reliability
transparency,
leverage
an
explainability-driven
performance
validation
strategy
investigate
decision-making
behavior
doing
so
ensure
COVIDNet-CT
makes
predictions
based
relevant
indicators
images.
Both
COVIDx-CT
available
general
public
open-source
open
access
manner
part
COVID-Net
initiative.
While
not
yet
production-ready
solution,
hope
releasing
model
will
encourage
researchers,
clinicians,
citizen
scientists
alike
build
upon
them.
BMJ,
Journal Year:
2020,
Volume and Issue:
unknown, P. m1328 - m1328
Published: April 7, 2020
To
review
and
appraise
the
validity
usefulness
of
published
preprint
reports
prediction
models
for
diagnosing
coronavirus
disease
2019
(covid-19)
in
patients
with
suspected
infection,
prognosis
covid-19,
detecting
people
general
population
at
increased
risk
covid-19
infection
or
being
admitted
to
hospital
disease.
Viruses,
Journal Year:
2020,
Volume and Issue:
12(4), P. 372 - 372
Published: March 27, 2020
The
outbreak
of
emerging
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
disease
(COVID-19)
in
China
has
been
brought
to
global
attention
and
declared
a
pandemic
by
the
World
Health
Organization
(WHO)
on
March
11,
2020.
Scientific
advancements
since
(SARS)
2002~2003
Middle
East
(MERS)
2012
have
accelerated
our
understanding
epidemiology
pathogenesis
SARS-CoV-2
development
therapeutics
treat
viral
infection.
As
no
specific
vaccines
are
available
for
control,
epidemic
COVID-19
is
posing
great
threat
public
health.
To
provide
comprehensive
summary
health
authorities
potential
readers
worldwide,
we
detail
present
introduce
current
state
measures
this
review.
Applied Intelligence,
Journal Year:
2020,
Volume and Issue:
51(2), P. 854 - 864
Published: Sept. 5, 2020
Chest
X-ray
is
the
first
imaging
technique
that
plays
an
important
role
in
diagnosis
of
COVID-19
disease.
Due
to
high
availability
large-scale
annotated
image
datasets,
great
success
has
been
achieved
using
convolutional
neural
networks
(CNN
s)
for
recognition
and
classification.
However,
due
limited
medical
images,
classification
images
remains
biggest
challenge
diagnosis.
Thanks
transfer
learning,
effective
mechanism
can
provide
a
promising
solution
by
transferring
knowledge
from
generic
object
tasks
domain-specific
tasks.
In
this
paper,
we
validate
deep
CNN,
called
Decompose,
Transfer,
Compose
(DeTraC),
chest
images.
DeTraC
deal
with
any
irregularities
dataset
investigating
its
class
boundaries
decomposition
mechanism.
The
experimental
results
showed
capability
detection
cases
comprehensive
collected
several
hospitals
around
world.
High
accuracy
93.1%
(with
sensitivity
100%)
was
normal,
severe
acute
respiratory
syndrome
cases.
European Journal of Clinical Microbiology & Infectious Diseases,
Journal Year:
2020,
Volume and Issue:
39(7), P. 1379 - 1389
Published: April 27, 2020
Early
classification
of
2019
novel
coronavirus
disease
(COVID-19)
is
essential
for
cure
and
control.
Compared
with
reverse-transcription
polymerase
chain
reaction
(RT-PCR),
chest
computed
tomography
(CT)
imaging
may
be
a
significantly
more
trustworthy,
useful,
rapid
technique
to
classify
evaluate
COVID-19,
specifically
in
the
epidemic
region.
Almost
all
hospitals
have
CT
machines;
therefore,
images
can
utilized
early
COVID-19
patients.
However,
CT-based
involves
radiology
expert
considerable
time,
which
valuable
when
infection
growing
at
rate.
Therefore,
an
automated
analysis
desirable
save
medical
professionals'
precious
time.
In
this
paper,
convolutional
neural
networks
(CNN)
used
COVID-19-infected
patients
as
infected
(+ve)
or
not
(-ve).
Additionally,
initial
parameters
CNN
are
tuned
using
multi-objective
differential
evolution
(MODE).
Extensive
experiments
performed
by
considering
proposed
competitive
machine
learning
techniques
on
images.
shows
that
model
good
accuracy
Nature Communications,
Journal Year:
2020,
Volume and Issue:
11(1)
Published: Aug. 14, 2020
Chest
CT
is
emerging
as
a
valuable
diagnostic
tool
for
clinical
management
of
COVID-19
associated
lung
disease.
Artificial
intelligence
(AI)
has
the
potential
to
aid
in
rapid
evaluation
scans
differentiation
findings
from
other
entities.
Here
we
show
that
series
deep
learning
algorithms,
trained
diverse
multinational
cohort
1280
patients
localize
parietal
pleura/lung
parenchyma
followed
by
classification
pneumonia,
can
achieve
up
90.8%
accuracy,
with
84%
sensitivity
and
93%
specificity,
evaluated
an
independent
test
set
(not
included
training
validation)
1337
patients.
Normal
controls
chest
CTs
oncology,
emergency,
pneumonia-related
indications.
The
false
positive
rate
140
laboratory
confirmed
(non
COVID-19)
pneumonias
was
10%.
AI-based
algorithms
readily
identify
well
distinguish
non-COVID
related
high
specificity
patient
populations.
Journal of Medical Virology,
Journal Year:
2020,
Volume and Issue:
92(6), P. 667 - 674
Published: March 13, 2020
Starting
around
December
2019,
an
epidemic
of
pneumonia,
which
was
named
COVID-19
by
the
World
Health
Organization,
broke
out
in
Wuhan,
China,
and
is
spreading
throughout
world.
A
new
coronavirus,
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
Coronavirus
Study
Group
International
Committee
on
Taxonomy
Viruses
soon
found
to
be
cause.
At
present,
sensitivity
clinical
nucleic
acid
detection
limited,
it
still
unclear
whether
related
genetic
variation.
In
this
study,
we
retrieved
95
full-length
genomic
sequences
SARAS-CoV-2
strains
from
National
Center
for
Biotechnology
Information
GISAID
databases,
established
reference
sequence
conducting
multiple
alignment
phylogenetic
analyses,
analyzed
variations
along
SARS-CoV-2
genome.
The
homology
among
all
viral
generally
high,
them,
99.99%
(99.91%-100%)
at
nucleotide
level
(99.79%-100%)
amino
level.
Although
overall
variation
open-reading
frame
(ORF)
regions
low,
13
sites
1a,
1b,
S,
3a,
M,
8,
N
were
identified,
positions
nt28144
ORF
8
nt8782
1a
showed
mutation
rate
30.53%
(29/95)
29.47%
(28/95),
respectively.
These
findings
suggested
that
there
may
selective
mutations
SARS-COV-2,
necessary
avoid
certain
when
designing
primers
probes.
Establishment
could
benefit
not
only
biological
study
virus
but
also
diagnosis,
monitoring
intervention
infection
future.